Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe crawled date : 2022 - 02 - 24 save search
US-Authorized COVID-19 Vaccines Generate More Than $30 Billion in 2021
Published: 2022-02-24 (Crawled : 23:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
covid-19 covid authorized vaccine
CytRx Comments on Orphazyme's Update on European Union Regulatory Review of Arimoclomol in Niemann-Pick Disease Type C
Published: 2022-02-24 (Crawled : 20:00) - biospace.com/
CYTR | $0.092
|
Manufacturing
|
| O: -0.88%
H: 11.5%
C: 2.68%
ema europe disease
Insurance Brokerage Market in Europe to grow by USD 7.60 bn |Technavio
Published: 2022-02-24 (Crawled : 18:00) - prnewswire.com
AON | $309.925 0.4% 120K
|
Finance
|
| O: -1.75%
H: 4.93%
C: 4.64%
europe insurance
Acaricides Market In Europe records a CAGR of 4.67% by 2026|Discover Company Insights in Technavio
Published: 2022-02-24 (Crawled : 18:00) - prnewswire.com
DOW | News A | $56.83 0.6% 570K
|
Process Industries
|
| O: -1.82%
H: 0.0%
C: 0.0%
europe
Seagen and Genmab Present First Data on Tisotumab Vedotin (TIVDAK®) in Patients with Head and Neck Squamous Cell Carcinoma
Published: 2022-02-24 (Crawled : 17:00) - biospace.com/
GNMSF | $290.38 220
|
Health Technology
|
| O: -0.93%
H: 5.16%
C: 5.16%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: -1.6%
H: 7.46%
C: 7.28%
GMAB | $28.67 1.2% 41K
|
Health Technology
|
| O: -2.63%
H: 0.0%
C: 0.0%
tivdak cel head and neck cell carcinoma
Destiny pushes European ambitions with the new name 'Dstny'
Published: 2022-02-24 (Crawled : 13:30) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -9.01%
H: 0.0%
C: 0.0%
europe
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce the Submission of a Marketing Authorization Application to the European Medicines Agency for PRX-102 for the Treatment of Fabry Disease
Published: 2022-02-24 (Crawled : 12:30) - prnewswire.com
PLX | $1.13 310K
|
Health Services
|
| O: -5.77%
H: 3.69%
C: 1.25%
prx-102 treatment europe application rare therapeutics disease authorization iot submission prx012
Grifols signs global collaboration and licensing agreement with Endpoint Health to develop and commercialize Antithrombin III for Sepsis
Published: 2022-02-24 (Crawled : 12:00) - biospace.com/
GRFS | News | $6.36 -2.75% 210K
|
Health Technology
|
| O: -1.73%
H: 0.79%
C: -0.53%
health collaboration license commercialization
Lime Market in Europe to grow by 4.09 million metric tons | Upsurge in Building and Construction Industry to Drive Global Construction Materials Market |Technavio
Published: 2022-02-24 (Crawled : 12:00) - prnewswire.com
MTX | $71.53 0.73% 16K
|
Process Industries
|
| O: -2.51%
H: 0.77%
C: -2.3%
CRH | $77.54 0.52% 900K
|
Non-Energy Minerals
|
| O: -6.62%
H: 2.61%
C: 2.4%
als europe
Addex to Present at the Virtual Sachs Associates 3rd Annual European HealthTech and 15th Annual European Life Sciences CEO Forums
Published: 2022-02-24 (Crawled : 08:00) - biospace.com/
ADXN | News | $20.96 3.1K
|
Health Technology
|
| O: -0.18%
H: 2.53%
C: 2.53%
health europe ceo life science
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.3022 24.82% 51M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.